Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China · Delayed Price · Currency is CNY 19.06
+1.20 (6.72%)
Jul 1, 2026, 3:00 PM CST
SHA:688298 Market Cap
SHA:688298 has a market cap or net worth of 3.68 billion as of July 1, 2026. Its market cap has decreased by -23.67% in one year.
Market Cap
3.68B
Enterprise Value
1.70B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.06
Market Cap Chart
Since February 5, 2020, SHA:688298's market cap has decreased from 17.52B to 3.68B, a decrease of -78.98%. That is a compound annual growth rate of -21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 3.68B | -18.65% |
| Dec 31, 2025 | 4.53B | -20.12% |
| Dec 31, 2024 | 5.67B | -21.40% |
| Dec 29, 2023 | 7.21B | -44.35% |
| Dec 30, 2022 | 12.95B | -53.17% |
| Dec 31, 2021 | 27.66B | 13.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hangzhou AGS MedTech | 4.04B |
| Shanghai Aohua Photoelectricity Endoscope | 3.82B |
| Getein Biotech | 3.81B |
| GKHT Medical Technology | 3.80B |
| Guangdong Biolight Meditech | 3.80B |
| Nanjing Medlander Medical Technology | 3.60B |
| Chison Medical Technologies | 3.36B |
| Wuhan Easy Diagnosis Biomedicine | 3.13B |